What are Digital Therapeutics?

“Digital therapeutics (DTx) deliver evidence-based therapeutic interventions to patients that are driven by high quality software programs to prevent, manage, or treat a medical disorder or disease. They are used independently or in concert with medications, devices, or other therapies to optimize patient care and health outcomes.

DTx products incorporate advanced technology best practices relating to design, clinical validation, usability, and data security. They are validated by regulatory bodies as required to support product claims regarding risk, efficacy, and intended use.

Digital therapeutics empower patients, healthcare providers, and payers with intelligent and accessible tools for addressing a wide range of conditions through high quality, safe, and effective data-driven interventions.” (https://www.dtxalliance.org/)


Digital Therapeutics Alliance

Founded in 2017, the Digital Therapeutics Alliance is a non-profit trade association of industry leaders and stakeholders engaged in the evidence-driven advancement of digital therapeutics. DTA maintains an international industry focus and is headquartered in the United States.

DTA exists to broaden the understanding, adoption, and integration of clinically-validated digital therapeutics into healthcare through education, advocacy, and research.

Alliance members work to enable expanded access to high quality, evidence-based digital therapeutics for patients, healthcare providers, and payers in order to improve clinical and health economic outcomes.


Digital Therapeutics: Combining Technology and Evidence-based Medicine to Transform Personalized Patient Care

DTA’s comprehensive report, provides an overview of the DTx industry and establishes the definition of a digital therapeutic. Core principles and best practices related to the design, manufacture, clinical validation, and regulatory oversight of these products are also featured. You can download the report here:


Examples of Digital Therapeutics already in the market or under development:



Big Health - Sleepio.

Digital therapeutic for sleep and insomnia


Big Health - Daylight.

Digital therapeutic for worry and anxiety.


OMADA Health: Changing lives, one small habit at a time.

“The CDC has called chronic disease “the public health challenge of the 21st century.”

One out of three Americans will die prematurely from a condition that’s mostly related to lifestyle, habit, or circumstance. These are conditions that pills and procedures can control but not fix, like type 2 diabetes or heart disease.

Omada uses behavior science to help people change their habits, improve their health and reduce their risk of chronic disease.”

CDC Recognizes Omada Health’s Prevent for Use in Its Diabetes Prevention Program



Omada Health: Digital Therapeutics for chronic disease

(Prediabetes, T2DM, HTN, High Cholesterol)


Meru Health.png

Meru Health:

Digital Clinic for Mental Health

Meru Health is an online medical clinic treating depression and burnout in San Francisco Bay Area, CA.

Meru Health's digital clinic offers an app-based treatment program that is supported by licensed therapists.

Meru Health individualizes the program based on patient’s personal information and needs.


Pear .png

Pear Therapeutics:

Prescription Digital Therapeutics for the treatment of serious disease.

Pear’s Product Pipeline



Screen Shot 2019-08-26 at 3.44.34 PM.png

Relieving the burden of disease caused by behaviors




Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.



Dthera Sciences. (AD)

Under development

Dthera Sciences (OTCQB: DTHR) is a publicly traded digital therapeutics company focused on the elderly and individuals with neurodegenerative diseases.



Welldoc. (T2DM)

Welldoc's BlueStar, is an award-winning digital therapeutic that is the cornerstone of chronic care management strategies, with a focus on type 2 diabetes.



Propeller Health: Leading digital therapeutics company.

Propeller helps you understand your symptoms, stick to your medication plan and build a stronger connection to your doctor.


Dario .png

DarioHealth is a leading Digital Therapeutics (DTx) company, revolutionizing the way people manage their health across the chronic condition spectrum.



GAIA-Digital Therapeutics

GAIA is a global pioneer in digital therapeutics, successfully launching its first product in 2001.



Products in Diabetes, Oncology & Other:



MOBIO Interactive.png


Mobio Interactive (MI) is a digital therapeutics and performance enhancement company empowering better living and faster healing.


“Effects of a Mindfulness Meditation App on Subjective Well-Being: Active Randomized Controlled Trial and Experience Sampling Study”



Amicomed is a digital platform for blood pressure management combining unprecedented data analysis with lifestyle intervention.



Bold Health.png

Personalised Digital Therapeutics For Hard-To-Treat-Conditions



Supporting digestive health through innovative, evidence-based digital therapeutics